BioSpace News Archive

Drug Development

OptiNose Breathes Easy Following Data From Phase III Sinusitis Trial

OptiNose announced positive top-line results from its Phase III ReOpen2 clinical trial testing OptiNose’s XHANCE, a fluticasone propionate nasal spray for chronic sinusitis.

June 13, 2022
·
2 min read
·
Hannah Chudleigh
Drug Development

CRISPR Tx Shares Fall as bluebird’s Gene Therapy Soars

Shares of CRISPR Therapeutics fell more than 11% on Monday as investors react negatively to the endorsement of a rival beta-thalassemia gene therapy developed by bluebird bio.

June 13, 2022
·
2 min read
·
Alex Keown
FDA

Ionis Scores Orphan, Rare Pediatric Disease Designations for Angelman Syndrome Candidate

ION582 is uniquely formulated using RNA technology to provide relief to patients with Angelman syndrome, a rare disorder for which limited treatment options are available.

June 13, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Drug Development

Versanis Hopes to Compete with Lilly, Novo in Weight Loss Space

Versanis Bio’s data reveals the results of a pooled analysis, showing that its lead asset, bimagrumab, improves body composition in both diabetic and non-diabetic patients.

June 13, 2022
·
3 min read
·
Tristan Manalac
Drug Development

Press Release: Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron

Sanofi reports data from two trials, VAT02 Cohort 2 and COVIBOOST VAT013, conducted with its new next-generation COVID-19 booster vaccine candidate modelled on the Beta variant antigen and including GSK’s pandemic adjuvant.

June 13, 2022
·
9 min read
Medical Radiation Shielding Market: Trends & Opportunities | Regional Outlook by 2031

The International Atomic Energy Agency describes the process of radiation protection or radiation shielding as the protection of humans from the negative impact they may receive when exposed to harmful values of ionizing radiation.

June 13, 2022
·
7 min read
Medical Foam Market Insights [Size | Shares | Trends | Growth | Industry Analysis] [2020-2030]

The rising disposable income of people around the world is promoting a shift from conventional to advanced wound care products, which in turn is providing a significant push to the global medical foam market.

June 13, 2022
·
7 min read
DiviTum®TKa Predicts Clinical Outcome of Patients in BioItaLEE Study

Biovica announced that the company’s blood test DiviTum®TKa was highlighted in an oral presentation on June 6th at the ASCO Annual Meeting from the BioItaLEE trial.

June 13, 2022
·
3 min read
Business

Evonetix Appoints Colin McCracken as Chief Executive Officer

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the appointment of Colin McCracken as Chief Executive Officer with immediate effect.

June 13, 2022
·
3 min read
Biotech Beach

Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform

Ainnocence, a global biotech startup on a mission to accelerate drug discovery using a fast, self-evolving AI drug design platform, launched at the 2022 BIO International Convention.

June 13, 2022
·
2 min read